• Price

Supplier Type

• Manufacturer
• Trader
• Reagent
• custom synthesis
• contract manufacturer

Supplier Region

• Hyderabad(8)
• Gujarat(10)
• Andhra Pradesh(1)
• Maharashtra(10)
• Ahmedabad(3)
• Mumbai(7)
• Vadodara(1)
• Karnataka(3)
• New Delhi(2)
• Uttar Pradesh(1)
• Delhi(6)
• Nagpur(1)
• Tamil Nadu(1)
• Punjab(1)
• Himachal Pradesh(1)

Purity

• VETRANAL?, analytical standard
• United States Pharmacopeia (USP) Reference Standard
• Tamoxifen is a potent synthetic anti-estrogenic agent.
• suitable for fluorescence, 98.0-102.0% (HPLC)
• solution, suitable for blocking, sterile
• solid
• recombinant, expressed in Pichia pastoris, suitable for cell culture
• purum, ≥97.0% (HPLC)
• purified immunoglobulin, buffered aqueous solution
• pure
• powder, contains NaCl as solubilizer
• powder, BioReagent, suitable for cell culture
• powder
• phyproof? Reference Substance
• pharmaceutical secondary standard, certified reference material
• Pharmaceutical Secondary Standard
• PESTANAL?, analytical standard
• NLT 95%
• more than 95 % (in HPLC)
• mixture of endo/exo 95%
• mitochondrial hexokinase inhibitor
• Min. 99%
• Indole alkaloid that binds to tubulin, inhibiting formation of microtubules.
• IL-2, recombinant, expressed in HEK 293 cells, suitable for cell culture, endotoxin tested
• IL-2, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
• Hybri-Max?, 50?×, γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma
• HCl 96%
• Greater than 99%
• for synthesis
• European Pharmacopoeia (EP) Reference Standard
• DNA synthesis and methylation inhibitor
• crystalline
• CRS, European Pharmacopoeia (EP) Reference Standard
• clone 41AT858.235, IgG fraction of antiserum, buffered aqueous solution
• clone 1E7, purified immunoglobulin, buffered aqueous solution
• certified reference material, pharmaceutical secondary standard
• Certified Reference Material
• British Pharmacopoeia (BP) Reference Standard
• Antitumor and antileukemic agent isolated from the bark of the yew tree.
• analytical standard, for drug analysis
• analytical standard
• AldrichCPR
• ABOVE 99%
• A phenolic product found in both grape skins and wines.
• A cell-permeable powerful DNA topoisomerase I inhibitor.
• A cell-permeable DNA topoisomerase I inhibitor.
• 99+%
• 99.9%
• 99.9
• >99.0%(GC)
• ≥99.0% (TLC)
• ≥99.0% (sum of enantiomers, HPLC)
• 99%+
• ≥99% (HPLC)
• 99%
• 98.50%
• 98.0-102.0% (HPLC)
• 98.0-102.0%
• 98.0-102%
• >98.0%(T)(HPLC)
• >98.0%(N)
• >98.0%(HPLC)(qNMR)
• >98.0%(HPLC)(N)
• >98.0%(HPLC)
• >98.0%(GC)(T)
• >98.0%(GC)
• 98% Min
• ≥98% (perchloric acid titration)
• ≥98% (HPLC), solid
• ≥98% (HPLC), powder
• ≥98% (HPLC)
• 98%
• ≥98%
• >98%
• 98 %
• 97-99 %
• ≥970?μg/mg (USP XXIV)
• >97.5% (Pt analysis)
• >97.0%(T)(HPLC)
• >97.0%(T)
• >97.0%(N)
• >97.0%(HPLC)(N)
• >97.0%(HPLC)
• ≥97% (HPLC)
• 97%
• >95.0%(HPLC)
• ≥95% (HPLC)
• ≥95%
• 95%
• ≥90% (HPLC), powder
• ≥90% (HPLC)
• 90%
• >85.0%(HPLC)
• 100%
• 10.0?mg/mL (12.5 mM Histidine Buffer), certified reference material, Cerilliant?
• 1?mg/mL in acetonitrile, certified reference material, ampule of 1?mL, Cerilliant?
• 1.5-2.0U/mg
• 1.0?mg/mL in methanol with 0.1N NaOH, ampule of 1?mL, certified reference material, Cerilliant?
• 0.2 μm filtered
• ~1.25?M HCl (T), for GC derivatization, LiChropur?
• &ge

Package

• 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
• 10g,10g
• 0.18
• 1g,1g
• 0MG TO GRAM
• 10μg
• 20μg
• 50μg
• 5x10μg
• 100μg
• 351μg
• 500μg
• 1mg
• 1.01mg
• 2mg
• 2.5mg
• 4.96mg
• 5MG-F
• 5mg
• 7mg
• 5x2mg
• 10mg
• 15mg
• 10x2mg
• 20mg
• 25MG-F
• 25mg
• 40mg
• 50mg
• 55mg
• 60mg
• 70mg
• 75mg
• 80mg
• 100MG
• 110mg
• 120mg
• 125mg
• 130mg
• 150mg
• 200mg
• 250mg
• 0.25mL
• 300mg
• 350mg
• 400mg
• 500mg
• 0.5g
• 1g
• 1gm
• 1mL
• 5g
• 5gm
• 10gm
• 10g
• 20mL
• 25g
• 25gm
• 50g
• 100g
• 100mL
• 100gm
• 250mL
• 500g
• 1kg
• 5kg
• 10kg
• 25kg
• 100kg
• 500kg
• 1Gms
• 1MT
• 5Gms
• 10vials
• 15units
• 18%
• 100μL
• 400μL
• 10000units
• 5g,5g